Assessing the impact of COVID-19 on liver cancer management (CERO-19)

JHEP Reports - Tập 3 - Trang 100260 - 2021
Sergio Muñoz-Martínez1, Victor Sapena1, Alejandro Forner1, Jean-Charles Nault2,3,4, Gonzalo Sapisochin5, Lorenza Rimassa6,7, Bruno Sangro8, Jordi Bruix1, Marco Sanduzzi-Zamparelli1, Wacław Hołówko9, Mohamed El Kassas10, Tudor Mocan11, Mohamed Bouattour12, Philippe Merle13, Frederik J.H. Hoogwater14, Saleh A. Alqahtani15, Helen L. Reeves16, David J. Pinato17, Emmanouil Giorgakis18, Tim Meyer19
1BCLC group, Liver Unit, Hospital Clinic Barcelona, IDIBAPS, CIBERehd, University of Barcelona, Barcelona, Spain
2Service d’Hépatologie, Hôpital Avicenne, Hôpitaux Universitaires Paris-Seine-Saint-Denis, Assistance-Publique Hôpitaux de Paris, Bobigny, France
3Unité de Formation et de Recherche Santé Médecine et Biologie Humaine, Université Paris Nord, Paris, France
4Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université Paris, INSERM UMR 1138 Functional Genomics of Solid Tumors Laboratory, Paris, France
5Abdominal Transplant & HPB Surgical Oncology, University Health Network, Toronto General Hospital, University of Toronto, Toronto, Canada
6Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy
7Department of Biomedical Sciences, Humanitas University, Milan, Italy
8Unidad de Hepatología, Clínica Universidad de Navarra, IDISNA, CIBERehd, Pamplona, Spain
9Department of General, Transplant, and Liver Surgery, Medical University of Warsaw, Warsaw, Poland
10Endemic Medicine Department, Faculty of Medicine, Helwan University, Cairo, Egypt
113rd Medical Department, ‘Octavian Fodor’ Institute for Gastroenterology and Hepatology, Cluj-Napoca, Romania
12AP-HP, Hôpital Beaujon, Department of Digestive Oncology, Clichy, France
13Department of Hepatology, Groupement Hospitalier Lyon Nord, Lyon, France
14Department of Hepato-Pancreato-Biliary Surgery and Liver Transplantation, University Medical Center Groningen, Groningen, the Netherlands
15Department of Liver Transplant, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia
16Liver Unit, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
17Department of Surgery and Cancer, Imperial College London, London, UK
18Division of Transplantation, Department of Surgery, UAMS Medical Center, Winthrop P. Rockefeller Cancer Institute, Little Rock, AK, USA
19Department of Oncology, Royal Free Hospital, London, UK

Tài liệu tham khảo

Pinato, 2020, Clinical portrait of the SARS-CoV-2 epidemic in European patients with cancer, Canc Discov, 10, 1465, 10.1158/2159-8290.CD-20-0773 Pinato, 2020, Presenting features and early mortality from SARS-CoV-2 infection in cancer patients during the initial stage of the COVID-19 pandemic in Europe, Cancers (Basel), 12, 1, 10.3390/cancers12071841 Marjot, 2021, Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study, J Hepatol, 74, 567, 10.1016/j.jhep.2020.09.024 Iavarone, 2020, High rates of 30-day mortality in patients with cirrhosis and COVID-19, J Hepatol, 73, 1063, 10.1016/j.jhep.2020.06.001 Amaddeo, 2021, Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area, JHEP Rep, 10.1016/j.jhepr.2020.100199 Meyer, 2020 Boettler, 2020, Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic, JHEP Rep, 2, 100169, 10.1016/j.jhepr.2020.100169 Mehta, 2020, Surveillance and monitoring of hepatocellular carcinoma during the COVID-19 pandemic, Clin Gastroenterol Hepatol Kudo, 2020, Treatment of hepatocellular carcinoma during the COVID-19 outbreak: the Working Group report of JAMTT-HCC, Hepatol Res, 50, 1004, 10.1111/hepr.13541 Cucchetti, 2014, Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma, J Hepatol, 61, 333, 10.1016/j.jhep.2014.03.037 Chen, 2011, Delay in treatment of early-stage hepatocellular carcinoma using radiofrequency ablation may impact survival of cirrhotic patients in a surveillance program, J Surg Oncol, 103, 133, 10.1002/jso.21797 Hanna, 2020, Mortality due to cancer treatment delay: systematic review and meta-analysis, BMJ, 371 Rich, 2020, Hepatocellular carcinoma demonstrates heterogeneous growth patterns in a multi-center cohort of patients with cirrhosis, Hepatology, 72, 1654, 10.1002/hep.31159 Cheng, 2002, Predicting the probability of progression-free survival in patients with small hepatocellular carcinoma, Liver Transpl, 8, 323, 10.1053/jlts.2002.31749 Mehrara, 2014, Analysis of inter-patient variations in tumour growth rate, Theor Biol Med Model, 11, 21, 10.1186/1742-4682-11-21 Kay, 2019, Estimation of solid tumor doubling times from progression-free survival plots using a novel statistical approach, AAPS J, 21, 27, 10.1208/s12248-019-0302-5 Nalley, 2020, Navigating the COVID-19 pandemic as an oncology nurse, Oncol Times, 42, 11, 10.1097/01.COT.0000658676.19027.ca Paterson, 2020, Oncology nursing during a pandemic: critical reflections in the context of COVID-19, Semin Oncol Nurs, 36, 10.1016/j.soncn.2020.151028 Debes, 2020, Virtual empathy and liver cancer, Liver Int, 40, 2571, 10.1111/liv.14576 D’Alessio, 2020, COVID-19 and liver cancer clinical trials: not everything is lost, Liver Int, 40, 1541, 10.1111/liv.14532 Waterhouse, 2020, Early impact of COVID-19 on the conduct of oncology clinical trials and long-term opportunities for transformation: findings from an American Society of Clinical Oncology Survey, JCO Oncol Pract, 16, 417, 10.1200/OP.20.00275
Thông tin
Thông tin xuất bản

JHEP Reports

Tập 3

100260

Thông tin tác giả